24 May 2013
Keywords: halozyme, reduces, iop, animals, san, diego, usa-based
Article | 16 May 2005
San Diego, USA-based Halozyme Therapeutics says that animal trials of its recombinant human PH20 (rHuPH20) hyaluronidase enzyme are
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 May 2005
23 May 2013
© 2013 thepharmaletter.com